[
  {
    "ts": "2025-11-14T12:59:00+00:00",
    "headline": "Pharma ETFs in Spotlight Following Robust Q3 Earnings Results",
    "summary": "Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.",
    "url": "https://finance.yahoo.com/news/pharma-etfs-spotlight-following-robust-125900300.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "10fc0cfd-b499-32b5-907f-5817647b3297",
      "content": {
        "id": "10fc0cfd-b499-32b5-907f-5817647b3297",
        "contentType": "STORY",
        "title": "Pharma ETFs in Spotlight Following Robust Q3 Earnings Results",
        "description": "",
        "summary": "Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.",
        "pubDate": "2025-11-14T12:59:00Z",
        "displayTime": "2025-11-14T12:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/780f3ed4ed0b380d687c52a84b4582b8",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/F9Duz3IXY6vI3GQX0iFRbg--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/780f3ed4ed0b380d687c52a84b4582b8.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jvXjFQvI33DlpnQwQb.s8g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/780f3ed4ed0b380d687c52a84b4582b8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pharma-etfs-spotlight-following-robust-125900300.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pharma-etfs-spotlight-following-robust-125900300.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PJP"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "XPH"
            },
            {
              "symbol": "FTXH"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "IHE"
            },
            {
              "symbol": "PPH"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T08:00:00+00:00",
    "headline": "Is that pharma influencer human or AI?",
    "summary": "Agentic AI is making its way into pharma marketing — and raising a slew of potential challenges around regulations and ethics.",
    "url": "https://www.pharmavoice.com/news/ai-pharma-social-media-influencer-drug-eversana/805499/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "81684cb7-59ea-3441-803a-3330b5d1a0c2",
      "content": {
        "id": "81684cb7-59ea-3441-803a-3330b5d1a0c2",
        "contentType": "STORY",
        "title": "Is that pharma influencer human or AI?",
        "description": "",
        "summary": "Agentic AI is making its way into pharma marketing — and raising a slew of potential challenges around regulations and ethics.",
        "pubDate": "2025-11-14T08:00:00Z",
        "displayTime": "2025-11-14T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/387603e9df17fe4993a3a8927227cc90",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0Mnpxis3DLYK47xOYN_gwA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/387603e9df17fe4993a3a8927227cc90.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AV2yPZOZExC8AR3Q6SlpaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/387603e9df17fe4993a3a8927227cc90.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/ai-pharma-social-media-influencer-drug-eversana/805499/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pharma-influencer-human-ai-080000016.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T17:30:00+00:00",
    "headline": "AbbVie Partners with Award-Winning Filmmaker on Film About the Dynamic and Resilient Lives of Those Living with Blood Cancer",
    "summary": "AbbVie (NYSE: ABBV) announced today the launch of Second Winds, a new short film that captures the powerful, deeply personal journeys of three people living with chronic lymphoma leukemia (CLL), a common type of blood cancer effecting hundreds of thousands of people in the United States.1,2 Each person's dynamic story reveals how facing a life-changing diagnosis can bring clarity and purpose, sparking a renewed commitment to staying active and embracing what truly matters in their lives.",
    "url": "https://finance.yahoo.com/news/abbvie-partners-award-winning-filmmaker-173000945.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "44013553-b545-3c2d-bb19-1340d0e0e624",
      "content": {
        "id": "44013553-b545-3c2d-bb19-1340d0e0e624",
        "contentType": "STORY",
        "title": "AbbVie Partners with Award-Winning Filmmaker on Film About the Dynamic and Resilient Lives of Those Living with Blood Cancer",
        "description": "",
        "summary": "AbbVie (NYSE: ABBV) announced today the launch of Second Winds, a new short film that captures the powerful, deeply personal journeys of three people living with chronic lymphoma leukemia (CLL), a common type of blood cancer effecting hundreds of thousands of people in the United States.1,2 Each person's dynamic story reveals how facing a life-changing diagnosis can bring clarity and purpose, sparking a renewed commitment to staying active and embracing what truly matters in their lives.",
        "pubDate": "2025-11-14T17:30:00Z",
        "displayTime": "2025-11-14T17:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/18d46ffcaf94a864c99a866e1d2383f4",
          "originalWidth": 400,
          "originalHeight": 300,
          "caption": "Second Winds screening event in Los Angeles, featuring the film's subjects: Alejandro, Christina & Jeff.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5xUOtWg9wk5utwmpZaSdDw--~B/aD0zMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/18d46ffcaf94a864c99a866e1d2383f4.cf.webp",
              "width": 400,
              "height": 300,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QJ3R_E29w1WiFWaFEzC1CQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/18d46ffcaf94a864c99a866e1d2383f4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-partners-award-winning-filmmaker-173000945.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-partners-award-winning-filmmaker-173000945.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T23:11:58+00:00",
    "headline": "AbbVie (ABBV): Evaluating Valuation Following Strong Results, Dividend Hike, and Key Strategic Shifts",
    "summary": "AbbVie (ABBV) is back in the spotlight after announcing strong quarterly results and a 6% dividend increase. The company also made waves by shifting strategy away from its Calico Life Sciences partnership and updating investors on several fronts. See our latest analysis for AbbVie. AbbVie shares have outpaced much of the market lately, supported by upbeat earnings, a hefty dividend increase, and high-profile strategic refocusing. With a 29% year-to-date share price return and a standout 46%...",
    "url": "https://finance.yahoo.com/news/abbvie-abbv-evaluating-valuation-following-231158554.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "24fd4e8a-7ea8-372b-a6e4-58c0edbb4694",
      "content": {
        "id": "24fd4e8a-7ea8-372b-a6e4-58c0edbb4694",
        "contentType": "STORY",
        "title": "AbbVie (ABBV): Evaluating Valuation Following Strong Results, Dividend Hike, and Key Strategic Shifts",
        "description": "",
        "summary": "AbbVie (ABBV) is back in the spotlight after announcing strong quarterly results and a 6% dividend increase. The company also made waves by shifting strategy away from its Calico Life Sciences partnership and updating investors on several fronts. See our latest analysis for AbbVie. AbbVie shares have outpaced much of the market lately, supported by upbeat earnings, a hefty dividend increase, and high-profile strategic refocusing. With a 29% year-to-date share price return and a standout 46%...",
        "pubDate": "2025-11-14T23:11:58Z",
        "displayTime": "2025-11-14T23:11:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cbaG7tZ9A8mqrilci3AeIQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1OA9tdPdimVe1Dv1fa4MAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-evaluating-valuation-following-231158554.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-evaluating-valuation-following-231158554.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]